Logo
U.S. NALOXONE MARKET ANALYSIS
  2. / Market Insights
  3. U.S. Naloxone Market Analysis
all report title image

U.S. NALOXONE MARKET ANALYSIS

U.S. Naloxone Market, By Drug Type (Branded and Generic), By Route of Administration (Intranasal Administration, Intramuscular Administration, Intravenous Administration, and others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)

  • Published In : Aug 2024
  • Code : CMI4953
  • Pages :198
  • Formats :
      Excel and PDF
  • Industry : Pharmaceutical

Market Concentration and Competitive Landscape

U.S. Naloxone Market Concentration By Players

Close-monitor your Competitor's Move, Get Instant Access to the Report

Key Players Insights
  • Adapt Pharma Inc.
  • Mylan N.V.
  • Hospira Inc. (Pfizer Inc.)
  • Kaleo Inc.
  • Amphastar Pharmaceuticals Inc.
  • Emergent BioSolutions Inc.
  • Indivior PLC
  • Akorn, Inc.
  • Hikma Pharmaceuticals PLC
  • Viatris Inc.
  • Sandoz (a Novartis division)
  • Teva Pharmaceuticals
  • Amneal Pharmaceuticals
  • Somerset Pharma, LLC
  • Orexo AB
  • UCB Pharma
  • West Ward Pharmaceuticals
  • Purdue Pharma

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now

Press Release

U.S. Naloxone Market to Surpass US$ 1,086.1 Mn by 2031
Logo

Credibility and Certifications

ESOMAR
DUNS Registered
Clutch
DMCA Protected

9001:2015

Credibility and Certifications

27001:2022

Credibility and Certifications

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.